Cosgrove, Casey M <br/><br/>
Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival.  [electronic resource] 

 -  Gynecologic oncology  09 2017 
 - 588-595 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1095-6859 
<br/><br/><label>Standard No.: </label>10.1016/j.ygyno.2017.07.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Aged<br/>DNA Methylation<br/>DNA Mismatch Repair--genetics<br/>Disease-Free Survival<br/>Endometrial Neoplasms--chemistry<br/>Epigenesis, Genetic<br/>Female<br/>Gene Silencing<br/>Humans<br/>Lymphatic Metastasis<br/>Microsatellite Instability<br/>Middle Aged<br/>MutL Protein Homolog 1--analysis<br/>Mutation<br/>Neoplasm Grading<br/>Neoplasm Invasiveness--genetics<br/>Neoplasm Recurrence, Local--genetics<br/>Neoplasm Staging<br/>Tumor Burden--genetics